Furthermore, it is important to note the preferential expression of both BCL-XL and MCL-1 in tumor compared to the normal tissues (Figs. 1 and 2), which provides a basis for BH3 mimetics to selectively target the tumor tissue. Here, BCL2L1 is linked to neoplasm.